• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《阿那白滞素治疗掌跖脓疱病：一项随机、双盲、多中心、两阶段、适应性安慰剂对照试验（APRICOT）的结果》的回应：作者的回复

Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)': reply from the authors.

作者信息

Cro S, Smith C H

机构信息

Imperial Clinical Trials Unit, Imperial College London, London, W12 7RH, UK.

St John's Institute of Dermatology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK.

出版信息

Br J Dermatol. 2022 May;186(5):909-910. doi: 10.1111/bjd.20944. Epub 2022 Mar 2.

DOI:10.1111/bjd.20944
PMID:34878650
Abstract

We believe that there is significant interest in the role of IL-1 in the pathomechanism of palmoplantar pustulosis. However, the APRICOT study failed to demonstrate a therapeutic effect of the IL-1 receptor antagonist. So, we recommend that the authors perform an additional subgroup analysis based on the presence or absence of plaque psoriasis.

摘要

我们认为，白细胞介素-1（IL-1）在掌跖脓疱病发病机制中的作用备受关注。然而，APRICOT研究未能证明IL-1受体拮抗剂的治疗效果。因此，我们建议作者根据是否存在斑块状银屑病进行额外的亚组分析。

相似文献

1
Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)': reply from the authors.对《阿那白滞素治疗掌跖脓疱病：一项随机、双盲、多中心、两阶段、适应性安慰剂对照试验（APRICOT）的结果》的回应：作者的回复
Br J Dermatol. 2022 May;186(5):909-910. doi: 10.1111/bjd.20944. Epub 2022 Mar 2.
2
Response to 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)'.
Br J Dermatol. 2022 May;186(5):908. doi: 10.1111/bjd.20942. Epub 2022 Apr 8.
3
Treatment of pustular psoriasis with anakinra: a statistical analysis plan for stage 1 of an adaptive two-staged randomised placebo-controlled trial.用阿那白滞素治疗脓疱性银屑病：一项适应性两阶段随机安慰剂对照试验第 1 阶段的统计分析计划。
Trials. 2018 Oct 3;19(1):534. doi: 10.1186/s13063-018-2914-y.
4
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.一项随机安慰剂对照试验，评估阿那白滞素治疗脓疱型银屑病：APRICOT 试验第二阶段的统计分析计划。
Trials. 2020 Feb 10;21(1):158. doi: 10.1186/s13063-020-4103-z.
5
A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial.一项确定阿那白滞素治疗脓疱型银屑病疗效的小样本、随机、安慰剂对照试验：APRICOT试验研究方案
Trials. 2018 Aug 29;19(1):465. doi: 10.1186/s13063-018-2841-y.
6
Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).阿那白滞素治疗掌跖脓疱病：一项随机、双盲、多中心、两阶段、适应性安慰剂对照试验（APRICOT）的结果
Br J Dermatol. 2021 Aug 19;186(2):245-56. doi: 10.1111/bjd.20653.
7
Response to the article by Naik et al entitled "anakinra for refractory pustular psoriasis: A phase II, open label, dose-escalation trial".
J Am Acad Dermatol. 2023 Mar;88(3):e145-e146. doi: 10.1016/j.jaad.2022.10.058. Epub 2022 Nov 11.
8
Interventions for chronic palmoplantar pustulosis.慢性掌跖脓疱病的干预措施。
Cochrane Database Syst Rev. 2020 Jan 20;1(1):CD011628. doi: 10.1002/14651858.CD011628.pub2.
9
Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study.瑞典掌跖脓疱病的经济负担：一项基于人群的登记研究。
Acta Derm Venereol. 2023 Jan 9;103:adv00843. doi: 10.2340/actadv.v103.4501.
10
The challenge of palmoplantar pustulosis therapy: Are Interleukin-23 inhibitors an option?掌跖脓疱病治疗的挑战：白细胞介素-23抑制剂是一种选择吗？
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e907-e911. doi: 10.1111/jdv.17560. Epub 2021 Aug 18.

引用本文的文献

1
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications.白细胞介素-1 家族细胞因子在炎症性皮肤病中的作用：发病机制及潜在治疗意义。
Int J Mol Sci. 2022 Aug 22;23(16):9479. doi: 10.3390/ijms23169479.